The success of clinical trials is highly dependent on the intricacies of patient recruitment. Other challenges, from the costs of clinical supplies to the specific procedural requirements that can extend physicians’ time, can increase costs. There are also possible budgetary impacts of testing and regulatory requirements. Gaining a better understanding of what is involved in the cost of a clinical trial can help the entire process, enabling your procurement and finance teams to more accurately budget and execute the tasks needed for success.
In this paper we will demonstrate how using image analysis (IA) and implementing biomarker assessment can improve your return on investment (ROI), accelerate trials, and minimize budget impacts.
To learn more: Download the document now.